MedPath

Clinical research of Ganshuang granules on cirrhotic patients following chronic hepatitis B

Phase 4
Completed
Conditions
hepaticsclerosis
Registration Number
ITMCTR2000003466
Lead Sponsor
The Affiliated Hospital of Northwest Minzu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Guidelines for the prevention and treatment of chronic hepatitis B (2015)

Exclusion Criteria

Hepatitis A, C or D virus infection; Immune hepatitis, drug hepatitis, steatohepatitis; Combined with severe dysfunction of heart, lung, kidney, brain or other organs; Combined with malignant tumor or mental disease.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.